688266.SS SHH
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
1W: -7.2%
1M: -6.5%
3M: -19.3%
YTD: +14.6%
1Y: +3.6%
3Y: +131.0%
5Y: +46.2%
¥110.00 ($16.40)
+3.34 (+3.13%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM¥2B
Revenue
+145.6% YoY
¥552M
Net Income
+483.2% YoY
¥770M
Free Cash Flow
+457.3% YoY
84.9%
Gross Margin
-6.5%
Op. Margin
2.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE38.1%
ROA16.9%
ROIC511.8%
Valuation
P/E53.0
P/B16.9
EV/EBITDA53.1
Leverage
Debt/Equity0.50
Current Ratio2.50
Interest Cov.23.5x
Quality Scores
Piotroski F7/9
Altman Z11.20
Beneish M-2.83